Weihai Baihe Biology Technological Co., Ltd. Share Price

Equities

603102

CNE100005RB6

Food Processing

End-of-day quote Shanghai S.E. 23:00:00 16/07/2024 BST 5-day change 1st Jan Change
29.47 CNY -0.20% Intraday chart for Weihai Baihe Biology Technological Co., Ltd. +0.31% -24.01%

Financials

Sales 2022 725M 99.9M 7.68B Sales 2023 871M 120M 9.23B Capitalization 2.48B 342M 26.29B
Net income 2022 138M 19.01M 1.46B Net income 2023 169M 23.28M 1.79B EV / Sales 2022 2.07 x
Net cash position 2022 1.1B 151M 11.62B Net cash position 2023 1.13B 156M 12.01B EV / Sales 2023 1.55 x
P/E ratio 2022
18.5 x
P/E ratio 2023
14.7 x
Employees 1,120
Yield 2022
1.48%
Yield 2023
1.93%
Free-Float 39.52%
More Fundamentals * Assessed data
Dynamic Chart
Weihai Baihe Biology Technological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Weihai Baihe Biology Technological Co., Ltd.'s Equity Buyback Plan announced on March 25, 2023. CI
Weihai Baihe Biology Technological Co., Ltd.'s Equity Buyback announced on March 25, 2023, has closed with 1,020,400 shares, representing 1.59% for CNY 38.84 million. CI
Certain A Shares of Weihai Baihe Biology Technological Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JAN-2024. CI
Tranche Update on Weihai Baihe Biology Technological Co., Ltd.'s Equity Buyback Plan announced on March 25, 2023. CI
Weihai Baihe Biology Technological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Weihai Baihe Biology Technological Co., Ltd.'s Equity Buyback Plan announced on March 25, 2023. CI
Weihai Baihe Biology Technological Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Weihai Baihe Biology Technological Co., Ltd.'s Equity Buyback Plan announced on March 25, 2023. CI
Weihai Baihe Biology Technological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Weihai Baihe Biology Technological Co., Ltd.'s Equity Buyback Plan announced on March 25, 2023. CI
Weihai Baihe Biology Technological Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. CI
Weihai Baihe Biology Technological Co., Ltd. authorizes a Buyback Plan. CI
Certain A Shares of Weihai Baihe Biology Technological Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JAN-2023. CI
Weihai Baihe Biology Technological Co., Ltd.(SHSE:603102) added to Shanghai Stock Exchange Composite Index CI
More news
1 day-0.20%
1 week+0.31%
Current month-2.13%
1 month-6.33%
3 months-7.33%
6 months-24.44%
Current year-24.01%
More quotes
1 week
29.23
Extreme 29.23
30.21
1 month
28.67
Extreme 28.67
31.46
Current year
28.67
Extreme 28.67
39.77
1 year
28.67
Extreme 28.67
48.98
3 years
28.67
Extreme 28.67
80.77
5 years
28.67
Extreme 28.67
80.77
10 years
28.67
Extreme 28.67
80.77
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 08/10/13
Chairman 66 31/12/04
Director/Board Member 59 31/12/04
Members of the board TitleAgeSince
Chief Executive Officer 61 08/10/13
Director/Board Member 51 31/12/04
Chairman 66 31/12/04
More insiders
Date Price Change Volume
17/07/24 29.47 -0.20% 170,400
16/07/24 29.53 -0.81% 185,800
15/07/24 29.77 -0.43% 358,400
12/07/24 29.9 -0.37% 239,800
11/07/24 30.01 +2.18% 260,641

End-of-day quote Shanghai S.E., July 16, 2024

More quotes
Weihai Baihe Biology Technological Co Ltd is a China-based company specializing in the research, development, production and sales of nutritional and health food. The Company has formed various dosage forms such as soft capsules, hard capsules, tablets, powders, oral liquids, drops, bottled drinks and bagged drinks. The Company has independent brands such as Baihekang, Fuzi, Hongyangshen and Zulixing, which are aimed at different types of consumer groups such as families, infants, high-end people, middle-aged and elderly people. The Company's products are exported to the United States, Britain, Canada and other countries and regions.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 603102 Stock